$25.31
0.35% today
NYSE, Apr 01, 07:14 pm CET
ISIN
US5004723038
Symbol
PHG

Royal Philips NV Sponsored ADR Stock price

$25.40
-0.63 2.42% 1M
-7.32 22.37% 6M
+0.08 0.32% YTD
+6.23 32.46% 1Y
-2.86 10.12% 3Y
-11.03 30.28% 5Y
+0.31 1.22% 10Y
NYSE, Closing price Mon, Mar 31 2025
-0.24 0.94%
ISIN
US5004723038
Symbol
PHG
Sector

Key metrics

Market capitalization $23.50b
Enterprise Value $28.96b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 21.37
EV/Sales (TTM) EV/Sales 1.49
P/S ratio (TTM) P/S ratio 1.21
P/B ratio (TTM) P/B ratio 1.86
Dividend yield 3.49%
Last dividend (FY24) $0.89
Revenue growth (TTM) Revenue growth -0.76%
Revenue (TTM) Revenue $19.49b
EBIT (operating result TTM) EBIT $1.39b
Free Cash Flow (TTM) Free Cash Flow $1.36b
Cash position $2.49b
EPS (TTM) EPS $-0.82
P/E forward 26.20
P/S forward 1.18
EV/Sales forward 1.45
Short interest 0.12%
Show more

Is Royal Philips NV Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Royal Philips NV Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

8x Buy
44%
10x Hold
56%

Analyst Opinions

18 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

Buy
44%
Hold
56%

Financial data from Royal Philips NV Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
19,494 19,494
1% 1%
100%
- Direct Costs 11,086 11,086
4% 4%
57%
8,408 8,408
4% 4%
43%
- Selling and Administrative Expenses 3,626 3,626
4% 4%
19%
- Research and Development Expense 1,890 1,890
8% 8%
10%
2,893 2,893
29% 29%
15%
- Depreciation and Amortization 1,504 1,504
10% 10%
8%
EBIT (Operating Income) EBIT 1,389 1,389
59% 59%
7%
Net Profit -759 -759
51% 51%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about Royal Philips NV Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Royal Philips NV Sponsored ADR Stock News

Neutral
GlobeNewsWire
7 days ago
March 25, 2025 Amsterdam, the Netherlands –  Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that in 2024 it was the leading applicant in the field of medical technology at the European Patent Office (EPO), filing 594 Medtech patent applications. This achievement underscores the company's ongoing dedication to transforming healthcare delivery by integ...
Neutral
GlobeNewsWire
8 days ago
March 24, 2025 Interoperable AI-powered digital pathology workflows support confident cancer diagnosis Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its partnership with Ibex Medical Analytics (Ibex) and a new release of Philips IntelliSite Pathology Solution (PIPS) to further accelerate the adoption of ...
Neutral
GlobeNewsWire
8 days ago
March 24, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced it has convened the Annual General Meeting of Shareholders (AGM) 2025 and published the agenda with explanatory notes. As previously announced, the agenda includes:
More Royal Philips NV Sponsored ADR News

Company Profile

Royal Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Respiratory Care businesses. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Head office Netherlands
CEO Roy Jakobs
Employees 67,823
Founded 1891
Website www.philips.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today